MRPL32 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.489200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.249600E-01
Normal-vs-Stage2
7.519600E-01
Normal-vs-Stage3
5.541400E-01
Normal-vs-Stage4
8.436800E-01
Stage1-vs-Stage2
9.104600E-01
Stage1-vs-Stage3
5.492600E-01
Stage1-vs-Stage4
9.489400E-01
Stage2-vs-Stage3
5.072600E-01
Stage2-vs-Stage4
8.809800E-01
Stage3-vs-Stage4
6.219000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.934200E-01
Normal-vs-AfricanAmerican
8.881400E-01
Normal-vs-Asian
9.315000E-01
Caucasian-vs-AfricanAmerican
7.010400E-01
Caucasian-vs-Asian
3.455600E-01
AfricanAmerican-vs-Asian
8.223800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.334000E-01
Normal-vs-Female
8.991600E-01
Male-vs-Female
1.918350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.290040E-01
Normal-vs-Age(41-60Yrs)
7.709400E-01
Normal-vs-Age(61-80Yrs)
5.805200E-01
Normal-vs-Age(81-100Yrs)
4.706000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.277800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.085000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.737800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.402000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.832300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.261800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.741000E-01
Normal-vs-Daily Drinker
6.111800E-01
Normal-vs-Weekly Drinker
8.801600E-01
Normal-vs-Occasional Drinker
8.854400E-01
Normal-vs-Social Drinker
9.654800E-01
Non Drinker-vs-Daily Drinker
7.082400E-01
Non Drinker-vs-Weekly Drinker
4.170000E-01
Non Drinker-vs-Occasional Drinker
1.095380E-01
Non Drinker-vs-Social Drinker
1.416040E-01
Daily Drinker-vs-Weekly Drinker
6.348800E-01
Daily Drinker-vs-Occasional Drinker
2.429200E-01
Daily Drinker-vs-Social Drinker
2.963800E-01
Weekly Drinker-vs-Occasional Drinker
6.184000E-01
Weekly Drinker-vs-Social Drinker
7.264000E-01
Occasional Drinker-vs-Social Drinker
8.210600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.110400E-01
Normal-vs-Grade 2
9.260200E-01
Normal-vs-Grade 3
9.216600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.960400E-01
Grade 1-vs-Grade 3
8.654200E-01
Grade 1-vs-Grade 4
9.110400E-01
Grade 2-vs-Grade 3
8.997000E-01
Grade 2-vs-Grade 4
9.260200E-01
Grade 3-vs-Grade 4
9.216600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.641200E-01
Normal-vs-NonDiabetic
9.183200E-01
Diabetic-vs-NonDiabetic
3.120900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.533380E-01
Normal-vs-NoPancreatitis
7.444200E-01
Pancreatitis-vs-NoPancreatitis
1.032420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.244000E-01
Normal-vs-N1
8.029200E-01
N0-vs-N1
6.287000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.954200E-01
Normal-vs-TP53-NonMutant
6.556200E-01
TP53-Mutant-vs-TP53-NonMutant
1.103450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
